Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

Håkan Wennbo(AstraZeneca (Sweden)), Jan Törnell, Amel Gritli-Linde(University of Gothenburg), Claes Ohlsson(Sahlgrenska University Hospital), M Gebre‐Medhin(St. Paul's Hospital Millennium Medical College), Olle Isaksson(University of Gothenburg)
Journal of Clinical Investigation
December 1, 1997
Cited by 208


Related Papers